RARE - Ultragenyx to file for accelerated approval of rare metabolic disease candidate
2024-06-12 16:40:12 ET
More on Ultragenyx Pharmaceutical
- Ultragenyx: Modest Sales Growth, With Multiple Inflection Points Approaching
- Mereo spikes after mid-stage data for Ultragenyx-partnered bone disorder therapy
- Ultragenyx upped at Goldman Sachs on bone disorder treatment
- Ultragenyx Pharmaceutical, Inc. (RARE) Q1 2024 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Ultragenyx Pharmaceutical